McKesson Corp (MCK) Financial Statements
Industry: Drugs, Proprietaries & Druggists' Sundries (Wholesale)
In fiscal 2026, McKesson reported revenue of $403.43B, up 12.4% from $359.05B the year before. Net income was $4.76B (a 1.2% net margin), or $38.38 per diluted share. Gross margin was 3.6% and operating margin was 1.5%. Operating activities generated $6.16B of cash, leaving $5.72B of free cash flow. At fiscal year end, McKesson held $82.32B in total assets against $84.50B in total liabilities, including $3.98B of cash and equivalents.
Open the full interactive McKesson financials → Quarterly statements, key ratios, valuation history and price charts.
McKesson Key Stats
| Share Price | $961.88 |
|---|---|
| Market Cap | $114.66B |
| P/E Ratio | 25.1 |
| Revenue YoY Growth | +12.4% |
| 52-Week Range | $723.60 – $993.53 |
| Shares Outstanding | 118.7 million (basic, 2027 Q1) |
McKesson Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $238.23B | $263.97B | $276.71B | $308.95B | $359.05B | $403.43B |
| Cost of Goods Sold | $226.08B | $250.84B | $264.35B | $296.12B | $345.73B | $388.88B |
| Gross Profit | $12.15B | $13.13B | $12.36B | $12.83B | $13.32B | $14.55B |
| Operating Income | -$5.04B | $2.04B | $4.38B | $3.91B | $4.42B | $6.21B |
| Pre-Tax Income | -$5.03B | $1.93B | $4.63B | $3.79B | $4.36B | $6.20B |
| Income Tax | -$695.0M | $636.0M | $905.0M | $629.0M | $878.0M | $1.10B |
| Net Income | -$4.54B | $1.11B | $3.56B | $3.00B | $3.29B | $4.76B |
| Diluted EPS | -$28.26 | $7.23 | $25.03 | $22.39 | $25.72 | $38.38 |
McKesson Quarterly Results
| 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | |
|---|---|---|---|---|
| Revenue | $103.15B | $106.16B | $96.30B | $105.38B |
| Net Income | $1.11B | $1.19B | $1.68B | $614.0M |
| Diluted EPS | $8.92 | $9.59 | $13.55 | $5.15 |
McKesson Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.28B | $3.53B | $4.68B | $4.58B | $5.69B | $3.98B |
| Current Assets | $45.38B | $46.23B | $44.29B | $47.97B | $55.40B | $57.21B |
| Total Assets | $65.02B | $63.30B | $62.32B | $67.44B | $75.14B | $82.32B |
| Current Liabilities | $44.10B | $48.47B | $47.96B | $52.36B | $61.60B | $67.02B |
| Total Long-Term Debt | $7.15B | $5.88B | $5.59B | $5.63B | $5.65B | $6.53B |
| Total Liabilities | $65.04B | $65.57B | $64.18B | $69.41B | $77.21B | $84.50B |
| Shareholders' Equity | -$21.0M | -$2.27B | -$1.86B | -$1.97B | -$2.07B | -$2.17B |
McKesson Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $4.54B | $4.43B | $5.16B | $4.31B | $6.08B | $6.16B |
| Cash From Investing | -$415.0M | -$89.0M | -$542.0M | -$1.07B | -$733.0M | -$3.43B |
| Cash From Financing | -$1.69B | -$6.32B | -$4.37B | -$3.34B | -$3.96B | -$4.63B |
| Free Cash Flow | $4.09B | $4.05B | $4.77B | $3.88B | $5.55B | $5.72B |
Figures from McKesson's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full McKesson financials page for every line item.
McKesson Company Profile
| Ticker | MCK |
|---|---|
| Exchange | NYSE |
| Industry | Drugs, Proprietaries & Druggists' Sundries (Wholesale) |
| Headquarters | Irving, Texas |
| Incorporated in | Delaware |
| Fiscal Year End | March 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000927653 |
Frequently Asked Questions
What was McKesson's revenue in fiscal 2026?
McKesson (MCK) reported revenue of $403.43B for fiscal 2026.
What is McKesson's annual revenue history?
McKesson's annual revenue by fiscal year: 2021: $238.23B; 2022: $263.97B; 2023: $276.71B; 2024: $308.95B; 2025: $359.05B; 2026: $403.43B.
What was McKesson's net income in fiscal 2026?
McKesson reported net income of $4.76B for fiscal 2026.
What was McKesson's earnings per share (EPS) in fiscal 2026?
McKesson's diluted EPS was $38.38 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did McKesson generate in fiscal 2026?
McKesson generated $5.72B of free cash flow in fiscal 2026.
What was McKesson's revenue last quarter?
In its most recent reported quarter (2027 Q1), McKesson reported revenue of $105.38B.
How much debt does McKesson have?
McKesson reported $6.53B of long-term debt, including the current portion, at the end of fiscal 2026.
How many shares of McKesson are outstanding?
McKesson reported a weighted average of 118.7 million basic shares outstanding in 2027 Q1.
What is McKesson's market cap?
Based on its latest closing price, McKesson (MCK) has a market capitalization of about $114.66B.
When does McKesson's fiscal year end?
McKesson's fiscal year end, as registered with the SEC, is March 31.
Where is McKesson headquartered?
McKesson lists its business address in Irving, Texas in its SEC filings.